News releases

FRAMINGHAM, Mass., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced the Company is set to join the Russell 1000® Index at the conclusion of the quarterly IPO additions of

FRAMINGHAM, Mass., Nov. 30, 2021 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Founder and Chief Executive Officer, Jason Krantz, and its Chief Financial Officer, Rick Booth,

FRAMINGHAM, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced the closing of its previously announced underwritten public offering of 11,000,000 shares of its Class A

FRAMINGHAM, Mass., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced the pricing of an underwritten public offering of 11,000,000 shares of its Class A common stock at a

FRAMINGHAM, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced the commencement of an underwritten public offering of 11,000,000 shares of its Class A common stock.

Third quarter revenue grew 43% year-over-year to $43.1 million FRAMINGHAM, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended

Life sciences companies can now access more than 11 million worldwide expert profiles to gain an even deeper understanding of Chinese and Japanese healthcare markets FRAMINGHAM, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH ), an industry leader in healthcare commercial

FRAMINGHAM, Mass., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its third quarter ended September 30, 2021 financial results will be released on Monday, November

Life sciences companies can perform rapid, iterative analysis on medical and prescription claims data to develop customized reports that accelerate go-to-market activities FRAMINGHAM, Mass. --(BUSINESS WIRE)--Oct. 18, 2021-- Definitive Healthcare (Nasdaq: DH ), an industry leader in healthcare

FRAMINGHAM, Mass., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that Robert Musslewhite has joined the company as President, a newly created role on the company’s Executive Leadership Team.